Inhibitor compounds of phosphodiesterase type 10A

US9938269B2 · kind B2 · utility

Assignees

• Abb Vie Inc. · US
• Abb Vie Deutschland Gmbh & Co. KG · DE

Inventors

• Hervé Geneste · Schifferstadt, DE
• Michael Ochse · Wiesbaden, DE
• Karla Drescher · Ludwigshafen, DE
• Berthold Behl · Ludwigshafen, DE
• Loic Laplanche · Ludwigshafen, DE
• Jurgen Dinges · Wadsworth, US
• Clarissa Jakob · North Chicago, US
• Katja Jantos · Ludwigshafen, DE

Key dates

• Filing date: Jun 27, 2012
• Grant date: Apr 10, 2018
• Expiry date: Aug 29, 2034

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D413/14
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention relates to novel carboxamide compounds, pharmaceutical compositions containing them, and their use in therapy. The compounds possess valuable therapeutic properties and are particularly suitable for treating or controlling medical disorders selected from neurological disorders and psychiatric disorders, for ameliorating the symptoms associated with such disorders and for reducing the risk of such disorders.